Sigmund Freud University Vienna, FacutlVice Dean of Researchy fo Medicine, Vienna (Austria)
54
presentations
10
followers
4
more
presentations
in this session
The novel subcutaneously administered glycoprotein IIb/IIIa antagonist RUC-4 (Zalunfiban) did not cause thrombocytopenia in the phase 2a study of patients with ST-elevation myocardial infarction